What moved
1 findingHow to read these marks →- Decreases serious adverse event incidence
very limited
“Chondroitin was associated with statistically significantly lower odds of serious adverse events compared with placebo with Peto odds ratio of 0.40 (95% CI 0.19 to 0.82; n = 6 trials) (level of evidence, moderate).”
- Study
- meta-analysis
- Effect
- 0.4 odds ratio, 95% CI 0.19 to 0.82
- Population
- adults with osteoarthritis (knee, hip or hand); pooled across 6 trials
Study record
- Design
- meta-analysis
- Species
- human
- Population
- adults with osteoarthritis (knee, hip, or hand), pooled from 43 RCTs
- Participants
- 9,110
- Comparator
- placebo
- Duration
- not reported
- Endpoints measured
- 9